Print this Page

Venture Capital

CaliforniaCalifornia leads the country in total life sciences investment. The venture capital dollars raised in California in the first three quarters of 2012 is more than the combined total of the next eight states (MA, PA, TX, OH, WA, NJ, MN, IL), $1.98 billion to $1.93 billion, respectively.

Venture Capital

SNAPSHOT:
VENTURE CAPITAL
Avalon Ventures

Avalon Ventures
Avalon Ventures
“One thing that could be improved is taxes on capital gains. People who have made investments — where they hold their investment for five years — especially in biotech and healthcare investments, there should be no capital gains taxes on these investments. Investments in innovation, which are the core of job creation and stimulation, should be protected.”

Kevin Kinsella, Managing Director, Avalon Ventures

Read more…

SNAPSHOT:
VENTURE CAPITAL
Domain Associates

Domain Associates
Domain Associates
“It is important to remember that often the best returns in an asset class come by investing when capital flowing into that sector is down. And the worst returns come when capital floods in (think: internet and housing bubbles!). Thus, we think now is a great time to invest. We believe returns going forward will be high and in the process human health will be improved and jobs will be created.”

Brian Halak, Partner, Domain Associates

Read more…

SNAPSHOT:
VENTURE CAPITAL
Third Rock Ventures

Third Rock Ventures
Third Rock Ventures
“In the absence of venture capital, there are few other substantial sources to start promising, new companies. Venture capital is critical to the life sciences ecosystem in California and for creating vibrant, entrepreneurial companies.”

Mark A. Goldsmith, M.D., Ph.D., Venture Partner, Third Rock Ventures

Read more…

Permanent link to this article: http://www.californiabiomedreport.com/venture-capital/